anti-influenza mAbs (Augmenta)

N/A

Report date: 2025/03/14 16:52:03

Base Information

Drug Nameanti-influenza mAbs (Augmenta)

Drug Alias Namebroadly binding fully human mAbs (Augmenta)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsInfluenza A virus infectionsInfluenza B virus infection

Inactive IndicationsN/A

ATC CodeN/A